The FDA and The Center for Drug Evaluation and Research is currently reviewing reports of an increased risk of suicide, suicidal thinking and attempts related to the use of the drug Paxil in “children, adolescents and adults” with major depressive disorder (MDD). These agencies are also looking at an increased incidence of self-mutilation, self-harm and related agitation surrounding the antidepressant drug Paxil.

Leave a Reply

Your email address will not be published. Required fields are marked *